Participants in Nigeria Vaccinated in First-Ever Ph 2 Lassa Fever Vaccine Trial
04 Apr 2024 //
ACCESSWIRE
IAVI Starts First-in-Human Ph I Trial of Single-Dose Virus Vaccine Candidate
27 Jun 2023 //
ACCESSWIRE
IAVI and BARDA Expand Partnership to Advance IAVI`s Filovirus Vaccine Candidates
02 Mar 2023 //
ACCESSWIRE
IAVI, BARDA Expand Partnership to Advance Filovirus Vaccine Candidates
02 Mar 2023 //
CONTRACT PHARMA
IAVI to Accelerate Investigational Sudan Ebolavirus Vaccine Development
25 Oct 2022 //
ACCESSWIRE
IAVI vaccinates first participants in Phase I Lassa fever vaccine trial
01 Sep 2022 //
CLINICALTRIALSARENA
Moderna, IAVI launch first-in-Africa trial of mRNA HIV vaccine
19 May 2022 //
SEEKING ALPHA
IAVI and Moderna Partner to Tackle Broad Global Health Priorities
07 Apr 2022 //
ACCESSWIRE
Moderna Starts Phase I of HIV Vaccine
28 Jan 2022 //
STAROBSERVER
GreenLight and IAVI partner for Phase I trial of Covid-19 vaccine in Africa
01 Dec 2021 //
CLINICALTRIALSARENA